Reactive arthritis natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) |
||
| Line 11: | Line 11: | ||
==Complications== | ==Complications== | ||
Complications of reactive arthritis are seen with chronic course and may include: | |||
*Chronic arthritis with remitting relapsing course | |||
*Urethral stricture | |||
*Vitreous floaters | |||
*Macular edema | |||
*Cataracts or glaucoma | |||
*Ankylosing spondylitis | |||
*Aortitis | |||
==Prognosis== | ==Prognosis== | ||
*Prognosis is generally good for patients with reactive arthritis.<ref name="pmid20216128">{{cite journal |vauthors=Wechalekar MD, Rischmueller M, Whittle S, Burnet S, Hill CL |title=Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab |journal=J Clin Rheumatol |volume=16 |issue=2 |pages=79–80 |date=March 2010 |pmid=20216128 |doi=10.1097/RHU.0b013e3181d06f70 |url=}}</ref><ref name="pmid7837155">{{cite journal |vauthors=Amor B, Santos RS, Nahal R, Listrat V, Dougados M |title=Predictive factors for the longterm outcome of spondyloarthropathies |journal=J. Rheumatol. |volume=21 |issue=10 |pages=1883–7 |date=October 1994 |pmid=7837155 |doi= |url=}}</ref> | *Prognosis is generally good for patients with reactive arthritis.<ref name="pmid20216128">{{cite journal |vauthors=Wechalekar MD, Rischmueller M, Whittle S, Burnet S, Hill CL |title=Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab |journal=J Clin Rheumatol |volume=16 |issue=2 |pages=79–80 |date=March 2010 |pmid=20216128 |doi=10.1097/RHU.0b013e3181d06f70 |url=}}</ref><ref name="pmid7837155">{{cite journal |vauthors=Amor B, Santos RS, Nahal R, Listrat V, Dougados M |title=Predictive factors for the longterm outcome of spondyloarthropathies |journal=J. Rheumatol. |volume=21 |issue=10 |pages=1883–7 |date=October 1994 |pmid=7837155 |doi= |url=}}</ref> | ||
Revision as of 18:46, 6 April 2018
|
Reactive arthritis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Reactive arthritis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Reactive arthritis natural history, complications and prognosis |
|
FDA on Reactive arthritis natural history, complications and prognosis |
|
CDC on Reactive arthritis natural history, complications and prognosis |
|
Reactive arthritis natural history, complications and prognosis in the news |
|
Blogs onReactive arthritis natural history, complications and prognosis |
|
Risk calculators and risk factors forReactive arthritis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Natural History
- The symptoms of reactive arthritis usually develop after 1-3 weeks of initial infection (in another part of the body) and start with symptoms such as malaise, fatigue, and fever.
- Majority of the patients have a self limited course with complete healing within 3-12 months.
- If left untreated, patients with reactive arthritis may progress to develop myalgias and joint pain especially in the lower extremities. Over the course of time, patient develops urethritis and conjunctivitis.
- Urethritis presents with dysuria, increased frequency, urgency, and urethral discharge whereas conjunctivitis leads to pain, burning, and tearing sensation in eyes.
Complications
Complications of reactive arthritis are seen with chronic course and may include:
- Chronic arthritis with remitting relapsing course
- Urethral stricture
- Vitreous floaters
- Macular edema
- Cataracts or glaucoma
- Ankylosing spondylitis
- Aortitis
Prognosis
- Prognosis is generally good for patients with reactive arthritis.[1][2]
- Patients who receive and respond to treatment generally have rapid reversal of symptoms.
- It is estimated that around 25% of patients develop long term complication of arthropathy.
- Long term complications are mostly seen in patients who are unresponsive to NSAIDs and have elevated ESR.
- Patients who are HLA-B27 positive have a high rate of recurrence (upto 50%).
References
- ↑ Wechalekar MD, Rischmueller M, Whittle S, Burnet S, Hill CL (March 2010). "Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab". J Clin Rheumatol. 16 (2): 79–80. doi:10.1097/RHU.0b013e3181d06f70. PMID 20216128.
- ↑ Amor B, Santos RS, Nahal R, Listrat V, Dougados M (October 1994). "Predictive factors for the longterm outcome of spondyloarthropathies". J. Rheumatol. 21 (10): 1883–7. PMID 7837155.